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Because (i) endothelial cells are important players in cardiovascular diseases and (ii) Mg deficiency promotes atherosclerosis, thrombosis
and hypertension, we evaluated whether low concentrations of Mg could directly affect endothelial behavior. We found that low Mg
concentrations reversibly inhibit endothelial proliferation, and this event correlates with a marked down-regulation of the levels of CDC25B.
The inhibition of endothelial proliferation is due to an up-regulation of interleukin-1 (IL-1), since an antisense oligonucleotide against IL-1
could prevent the growth inhibition observed in cells exposed to low concentrations of the cation. We also report the up-regulation of
Vascular Cell Adhesion Molecule-1 (VCAM) and Plasminogen Activator Inhibitor (PAI)-1 after Mg deficiency. VCAM is responsible, at
least in part, of the increased adhesion of monocytoid U937 cells to the endothelial cells grown in low magnesium. In addition, endothelial
migratory response is severely impaired. By cDNA array, we identified several transcripts modulated by exposure to low Mg, some of
which—c-src, ezrin, CD9, cytohesin and zyxin—contribute to endothelial adhesion to substrates and migration.
In conclusion, our results demonstrate a direct role of low magnesium in promoting endothelial dysfunction by generating a pro-
inflammatory, pro-thrombotic and pro-atherogenic environment that could play a role in the pathogenesis cardiovascular disease.
D 2004 Elsevier B.V. All rights reserved.Keywords: Endothelial cell; Magnesium; Atherosclerosis; Gene expression; Inflammation
1. Introduction secretion and cell permeability to lipids, enhancing LDLEndothelial cells maintain the functional integrity of the
vascular wall. Beyond their role in controlling permeability,
they are involved in the maintenance of a non-thrombogenic
blood–tissue interface, in the modulation of blood flow and
vascular resistance, in the regulation of immune and inflam-
matory reactions [1]. It is well accepted that endothelial
dysfunction plays an important pathogenic role in several
diseases, among which atherosclerosis [2], hypertension [3],
diabetes [1] and thrombosis [1]. In particular, a huge amount
of experimental evidence supports the paradigm of endo-
thelial dysfunction as the common link between risk factors
and atherosclerotic burden [2]. Indeed, endothelial dysfunc-
tion actively participates in the process of lesion formation
by promoting leukocyte adherence, increasing chemokine0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: jeanette.maier@unimi.it (J.A.M. Maier).oxidation, stimulating vascular smooth muscle cell prolifer-
ation and migration and platelet activation [2].
In addition, endothelial cells are protagonists in angio-
genesis, i.e. the branching and sprouting of capillaries from
preexisting blood vessels, which is a tightly controlled
event crucial in development, in reproduction and wound
healing [4].
Because of their strategical location at the interface
between blood and vessels, endothelial cells are readily
exposed to various signals (cytokines, metabolites, ions,
free radicals, shear stress), some of which may promote
maladaptative functional changes. Among others, low mag-
nesium (Mg) status has been reported to be important in the
pathogenesis of cardiovascular diseases [5]. Interestingly,
low magnesium status, which is frequent in western
countries, is a common denominator in hypertension [6],
coronary artery disease [7], thrombosis [8] and diabetes [9].
During experimental Mg deficiency hyperlipemia, inflam-
mation and early atherosclerotic lesions have been observed
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in the inhibition of atherogenesis in APO-E-deficient mice
fed with a high cholesterol diet [11]. Oral Mg therapy has
been associated with significant improvement of endothelial
function in patients with coronary artery disease [12] and
with a decrease of plasma concentrations of triglycerides,
VLDL and apo-B [13]. Mg deprivation also reduces tumor
growth through unclear mechanisms [14]. Moreover, Mg is
important in wound healing, since elevation in the concen-
tration of Mg has been detected in early wound fluid, when
cell migration into the wound is initiated [15].
Since Mg deficiency promotes atherosclerosis, thrombo-
sis and hypertension, and inhibits tumor growth, all pro-Fig. 1. Inhibition of endothelial proliferation by low magnesium. (A) HUVEC we
Every 24 h, the cells were harvested by digestion with trypsin and viable cells coun
triplicate (out of five performed). Standard deviation never exceeded F 4500 cells
hours later, the medium was supplemented with Mg to 1.0 mM concentration. Ce
experiments, which were performed in triplicate. Standard deviation never exceede
performed).cesses which recognize the endothelial cell as a crucial
player, we have evaluated the effects of low concentrations
of Mg on cultured endothelial cells.2. Materials and methods
2.1. Cell culture, proliferation and migration
HUVEC were cultured in M199 containing 10% fetal
calf serum, Endothelial Cell Growth Supplement (ECGS)
(150 Ag/ml) and heparin (5 U/ml) on 2% gelatin-coated
dishes. The cells were routinely evaluated for the expressionre cultured for different times in media containing 0.1, 0.5 or 1.0 mM Mg.
ted using a Burker chamber. The figure shows a representative experiment in
. (B) HUVEC were cultured in medium containing 0.1 mM Mg. Forty-eight
lls were counted as described after 72 and 120 h from the beginning of the
d F 3700 cells. The figure shows a representative experiment (out of three
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VE-cadherin and CD34, and utilized for five to six passages.
All culture reagents were from Gibco. A magnesium-free
medium was purchased by Bio Media (Boussens, France)
and utilized to vary the concentrations of magnesium by the
addition of MgSO4. No significant difference was observedFig. 2. Induction of HUVEC/U937 interactions by low magnesium concentrations
and exposed or not to LPS (0.5 Ag/ml). After 4 h, U937 cells were added. One
attached U937 cells was counted in 20 microscopic fields defined by an eyepie
performed). (B) Adhesion assay as described above was performed in the presence
were added with the same concentration of nonimmune rabbit IgG. The experiment
shows a representative experiment (out of three performed). (C) Western blot was
using an anti-VCAM antibody as described in Materials and methods. Densitometr
mM Mg for 3 days. Exposure to IL-1 (20 ng/ml) for 8 h was considered a positiwhen we used MgSO4 or MgCl2 to add magnesium in the
culture media (not shown). In all the experiments the cells
were seeded in growth medium; after 24 h, the medium was
changed to expose the cells to various concentrations of Mg.
Proliferation assays were performed on HUVEC at low
density (7500/cm2), cultured in growth medium containing. (A) Confluent HUVEC were cultured in 0.1, 0.5 or 1.0 mM Mg for 3 days
hour later, the nonadherent U937 cells were rinsed off and the number of
ce. The figure shows a representative experiment in triplicate (out of six
of an anti-VCAM antibody (15 Ag/ml). Control cells in 0.1 and 1.0 mM Mg
was performed in triplicate. Data refer to meansF standard error. The figure
performed on HUVEC cultured in different concentrations of Mg for 3 days
ic analysis indicated that VCAM is threefold induced in cells cultured in 0.1
ve control and determined a fivefold induction.
Fig. 3. Induction of PAI-1 expression by low magnesium concentrations.
Western blot was performed on HUVEC cultured in different concen-
trations of Mg (1.0, 0.5 and 0.1 mM Mg) for 3 days as described in
Materials and methods. By densitometric analysis, PAI-1 is increased by 2-
and 3.8-fold in cells grown for 3 days in 0.5 and 0.1 mM Mg, respectively.
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cells were trypsinized, stained with trypan blue solution
(0.4%) and the viable cells were counted using a Burker
chamber. In some experiments, HUVEC were incubated in
the presence of an interleukin 1a (IL-1) antisense oligomer
(50 AM) designed to recognize nine nucleotides upstream
and nine downstream from the translation initiation codon
[16]. Since this oligonucleotide proved to efficiently inhibit
IL-1a translation [16], this is the only antisense oligomer we
utilized in our study. The antisense oligomer does not
modulate the levels of IL-1h [16]. As controls, we used
the same concentrations of the corresponding sense oligo-
mer. All the experiments have been repeated at least three
times, always in triplicate.
Migration of HUVEC cultured in the presence of differ-
ent concentrations of Mg was determined using an in vitro
model of wound repair as previously described [17]. Briefly,
confluent endothelial cells were wounded and treated with
Hepatocyte Growth Factor (HGF) (20 ng/ml) for 18 h. The
number of cells migrating from the wound origin was
counted with a light microscope at 100 magnification
using a grid. The values represent the meanF standard
deviation of five fields, each condition tested in triplicate.
The monocytoid cell line U937 was cultured in RPMI
medium containing 10% FCS.
2.2. Adhesion assay
Confluent HUVEC were cultured in 24-well plates in
medium containing different concentrations of Mg for
different times. In some cases, HUVEC were incubated in
the presence of IgGs against Vascular Cell Adhesion
Molecule-1 (VCAM) or nonimmune IgGs (Santa Cruz).
In other experiments, the cells were treated with lipopoly-
saccharide (LPS; 0.5 Ag/ml). At the end of the incubation,
the wells were rinsed three times and 2 105 U937 cells
were added to each well. After 1 h, the nonadherent U937
cells were rinsed off and the wells were fixed with 1%
glutaraldehyde. The number of attached U937 cells was
counted in 20 microscopic fields defined by an eyepiece.
The experiments were performed at least three times in
triplicate [18].
2.3. Western blot
HUVEC were lysed in 10 mM Tris–HCl (pH 7.4)
containing 3 mM MgCl2, 10 mM NaCl, 0,1% SDS, 0,1%
Triton X-100, 0,5 mM EDTA and protein inhibitors, sepa-
rated on 10% SDS-PAGE and transferred to nitrocellulose
sheets. Western blot analysis was performed using anti-
bodies against Plasminogen Activator Inhibitor (PAI)-1, src,
CDC25B or VCAM (Santa Cruz). Secondary antibodies
were labeled with horseradish peroxidase (Amersham Phar-
macia Biotech). The SuperSignal chemiluminescence kit
(Pierce) was used to detect immunoreactive proteins accord-
ing to the manufacturer’s instruction. All the Western blotshave been repeated at least three times on cell extracts from
different experiments.
2.4. IL-1a synthesis
HUVEC were cultured in media containing different
concentrations of Mg for different times. In another set of
experiments, the cells were cultured in 0.1 and 1.0 mM Mg
with an antisense oligomer against IL-1 and the corres-
ponding sense oligonucleotide. IL-1 concentration in cell
extracts was detected using Quantikine human IL-1 immu-
noassay according to the manufacturers’ instructions (R&D
Systems) [16]. The experiment has been repeated four times
in triplicate.
2.5. cDNA array
The RNA utilized in these experiments was extracted by
the cesium chloride method [18] from HUVEC cultured in
0.1 and 1.0 mM Mg for 3 days. Human cDNA expression
array membranes consisting of 588 known genes (Atlask
Human Cancer Array, Clontech, Palo Alto, CA, USA) were
used as described by themanufacturer. The hybridization data
were collected with PhosphoImager (Molecular Dynamics,
Sunnyvale, CA, USA). The AtlasImage 1.0 (Clontech) soft-
ware was used to compare gene expression. Signal intensities
between the compared arrays were normalized using the
global mode (to develop a normalization coefficient) that
uses an average value based on all the expressed genes. Genes
with a ratio of 2.0 or above were considered regulated.3. Results
3.1. Inhibition of endothelial proliferation by low Mg
HUVEC were grown in the presence of different con-
centrations of extracellular Mg for various times. The
considered physiological concentration of the cation is 1.0
mM Mg. In human, the lowest level of Mg in critically ill
subjects was 0.5 mM [19] and concentrations ranging
between 0.7 and 0.8 mM are frequent in apparently healthy
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diet, a decrease in plasma Mg to a 0.14 mM can be detected
[21,22]. Based on these findings, we utilized the following
concentrations of Mg in the culture media: 0.1, 0.5 and 1.0
mM. In agreement with results obtained in other cell typesFig. 4. IL-1 synthesis in low Mg and its role in modulating endothelial proliferatio
Mg. Cell extracts were utilized to measure the levels of IL-1 as described in Mat
figure shows the results of a representative experiment (out of three performed).
oligomer against IL-1 or its control sense oligonucleotide. Cell extracts were utilize
times, with similar results. (C) HUVEC were grown in medium containing 0.1 mM
corresponding sense oligomer (0.1 mM Mg+ sense). Every 48 h, cells were trypsin
used as a control. The experiment was performed in triplicate. Standard deviation
(out of three performed).[14], low Mg inhibited endothelial proliferation in a dose-
and time-dependent manner (Fig. 1A). This inhibition was
reversible: after 48 h in 0.1 mM Mg-containing medium, the
concentration of Mg was restored to 1.0 mM and HUVEC
rapidly began to grow as fast as the controls (Fig. 1B).n. (A) The cells were cultured in the presence of different concentrations of
erials and methods. Data are expressed as the meansF standard error. The
(B) HUVEC were cultured in 0.1 mM Mg in the presence of an antisense
d to measure the levels of IL-1 as above. The experiment was repeated three
Mg in the presence of an anti-IL-1 antisense (0.1 mM Mg+ antisense) or its
ized and counted with a haemocytometer. Cells grown in 1.0 mM Mg were
never exceededF 4500 cells. The figure shows a representative experiment
t Biophysica Acta 1689 (2004) 13–213.2. Modulation of endothelial adhesiveness and thrombotic
properties in HUVEC cultured in low Mg
Since one of the earliest events in the formation of the
atherosclerotic plaque is the adhesion of monocytes to the
endothelial lining, we evaluated the interaction of the
monocytoid U937 cells to HUVEC cultured in low Mg
for 3 days and found an increase in endothelial-U937 cell
interactions (Fig. 2A). This increased adhesion is due, at
least in part, to an up-regulation of VCAM. Indeed, when
we incubated the cells in the presence of 0.1 mM Mg and an
antibody against VCAM, we detected a significant reduction
of the adhesion between U937 cells and HUVEC (Fig. 2B),
whereas no effect was exerted by the antibody on cells
cultured in 1.0 mM Mg (not shown). Accordingly, 2.9-fold
increase of VCAM mRNAwas detected by quantitative RT-
PCR (not shown) and confirmed by Western blot (Fig. 2C).
Densitometric analysis indicated that VCAM is threefold
induced in cells cultured in 0.1 mM Mg for 3 days, while
exposure to IL-1 (20 ng/ml) for 8 h determines a fivefold
induction. No modulation of E-selectin and ICAM-1 was
found both by RT-PCR and Western blot in cells grown in
low Mg (not shown).
Bacterial LPS is a potent inducer of endothelial adhe-
siveness. When cultured in low concentrations of Mg for 3
days, endothelial response to LPS (0.5 Ag/ml) is markedly
increased in a dose-dependent fashion (Fig. 2A).
One of endothelial functions is the maintenance of non-
thrombogenic blood–tissue interface [1]. We evaluated the
expression of PAI-1, which is increased in a variety of
clinical conditions such as coronary artery disease and
venous thrombosis [23]. Fig. 3 shows higher amounts of
J.A.M. Maier et al. / Biochimica e18Fig. 5. Impairment of endothelial migration by low magnesium. After 3 days cul
treated with HGF (20 ng/ml) for 24 h. The number of cells migrating from the wou
a grid. The values represent the meanF standard deviation of five fields, each con
of six performed).PAI-1 (Mr 50 kDa) in HUVEC grown in low Mg-containing
medium than in controls as detected by Western blot
analysis. In particular, by densitometric analysis, PAI-1 is
increased by 2- and 3.8-fold in cells grown for 3 days in 0.5
and 0.1 mM Mg, respectively.
3.3. Enhancement of IL-1 synthesis in endothelial cells
cultured in low Mg
Elevated levels of circulating cytokines, among which
IL-1, have been detected in rats fed with low Mg diet [10].
IL-1 profoundly affects endothelial behavior and is a potent
inhibitor of endothelial cell growth [16,24]. We therefore
measured the synthesis of IL-1 in HUVEC grown in media
containing different concentrations of Mg for 3 and 6 days
by ELISA. We found that cells cultured in low Mg produce
higher amounts of the cytokine than controls and this event
was dose-dependent (Fig. 4A).
Since IL-1 is an antagonist of endothelial proliferation,
we anticipated that a link could exist between the increased
levels of IL-1 and the growth inhibition in HUVEC cultured
in low Mg. Therefore the cells were incubated in a medium
containing 0.1 mM Mg in the presence of an antisense
oligomer against IL-1, previously shown to be successful in
repressing IL-1 translation [16]. As demonstrated in Fig. 4B,
the antisense oligomer, but not the control sense oligonu-
cleotide, markedly reduced IL-1 levels in HUVEC cultured
in 0.1 mM Mg. Fig. 4C shows that the antisense oligomer
prevented the growth inhibition of HUVEC grown in Mg-
deficient medium, while the sense oligomer added to the
medium containing 0.1 mM Mg did not exert any effect on
cell proliferation.ture in low Mg containing medium, confluent HUVEC were wounded and
nd origin was counted with a light microscope at 100 magnification using
dition tested in triplicate. The figure shows a representative experiment (out
et Biophysica Acta 1689 (2004) 13–21 193.4. Inhibition of endothelial migration in HUVEC cultured
in low Mg
In several pathologic and pathophysiologic conditions as
well as in development, angiogenic factors stimulate endo-
thelial cells to migrate and then to proliferate [4]. The
response to HGF, an angiogenic factor, was then evaluated.
HUVEC were cultured in medium containing low concen-
trations of Mg for 3 days before the addition of HGF (20 ng/
ml) for additional 24 h. Fig. 5 shows that low Mg concen-
J.A.M. Maier et al. / BiochimicaFig. 6. Down-regulation of CDC25B and c-src by low magnesium. Cell
extracts from HUVEC cultured in 0.1 or 1.0 mM Mg were separated on a
10% SDS-PAGE, transferred to nitrocellulose and Western blot was
performed using (A) anti-CDC25B or (B) anti-c-src antibodies and
visualized by chemiluminescence as described. By densitometric analysis,
CDC25B is increased by ninefold in cells grown for 3 days in 0.1 mM Mg,
while c-src is threefold induced.trations impaired endothelial migration in a dose-dependent
manner. Similar results were obtained with Fibroblast
Growth Factor (FGF)-1 and -2 (not shown).
3.5. Modulation of gene expression in HUVEC cultured in
low Mg
In an effort to gain more insights into the response of
endothelial cells to low concentrations ofMg, we used cDNA
arrays to survey the transcriptional activity of a large number
of genes in HUVEC cultured in normal or lowMg-containing
medium for 3 days. Genes with a ratio of 2.0 or above were
considered positively regulated. Using these criteria, we
found six genes down-regulated: c-src (threefold reduction),
ezrin (sixfold), cytohesin (fourfold), CD9 (fourfold), zyxin
(fourfold) and CDC25B (14-fold). Two genes were found up-
regulated: the DNA excision repair protein ERCC1 (twofold)
and the AXL tyrosine kinase receptor (threefold).
Since low Mg impairs endothelial proliferation, a partic-
ular attention has been devoted to the modulation of
CDC25B, which plays a role in promoting cell cycle
progression. By Western blot analysis, we confirmed a
marked reduction (ninefold) in the total amount of CDC25B
(Fig. 6A). By the same technique, we also confirmed that
the total amount of c-src is reduced in HUVEC cultured in
low magnesium (threefold) (Fig. 6B).4. Discussion
Mg is the second most abundant intracellular cation, after
potassium, and is a cofactor in more than 300 enzymatic
reactions involving energy metabolism, protein and nucleic
acid synthesis. Indeed, it activates a large array of enzymes
either by bridging distinct molecules or by functioning as an
allosteric modulator through its interaction with negatively
charged moieties [25]. Compelling evidence shows that Mg
content correlates with normal cells proliferation since Mg
stimulates DNA and protein synthesis [26]. In addition, a
cellular calcium–Mg antagonism has been described and
considered relevant in modulating cell functions [27].
Evidence has accumulated to suggest that extracellular
Mg concentrations play a critical role in modulating endo-
thelial activities [28]. Indeed, Mg levels influence the
synthesis of nitric oxide [29], intracellular calcium release
[28], the uptake and metabolism of low-density lipoproteins
[30], the permeability to water and albumin [31], and the
proliferation of endothelial cells [32]. In addition, Mg
deficiency enhances free radical-induced cytotoxicity in
endothelial cells [33].
Because (i) endothelial cells are important players in
atherogenesis and angiogenesis, and (ii) Mg deficiency
promotes atherosclerosis, thrombosis, hypertension and
inhibits tumor growth, we asked whether low concentrations
of Mg could affect endothelial behavior. We focused our
attention on cell proliferation and migration, critical steps in
J.A.M. Maier et al. / Biochimica et Biophysica Acta 1689 (2004) 13–2120angiogenesis, on endothelial/mononuclear cell interactions,
early event in atherogenesis, and on the modulation of gene
expression.
We here demonstrate that low Mg concentrations inhibit
HUVEC proliferation, and this event correlates with a
marked down-regulation of the levels of CDC25B, a phos-
phatase which plays a key role in controlling G2–M
progression [34]. Indeed, the reduction in the levels of
CDC25B could explain the negative regulation of the
G2–M transition of vascular endothelial cells by the phor-
bol ester PMA and diacylglycerol [35].
The role of Mg in modulating eukaryotic cell growth is
controversial. Whereas studies in normal cells have estab-
lished a positive relation between the levels of Mg and the
extent of proliferation, conflicting results have been
obtained in tumor cells. For instance, low Mg medium
affected the growth of 3T3 fibroblasts, but not of their
transformed counterpart [26]. In accordance, it is notewor-
thy that Mg deficiency delays the transit through the G1 and
S phase of normal but not transformed cells [36].
We also show that endothelial cell growth inhibition is
reversible upon Mg re-supplementation, suggesting that no
permanent modifications occur as a consequence of the
deprivation of the cation. It is likely that the modulation
of cell growth by Mg is mediated by corresponding changes
in intracellular Mg, which would influence the activity of
enzymes crucial to the proliferation process. Moreover,
since Mg frequently acts as a natural Ca antagonist [37], it
is conceivable to propose that an imbalance between Ca and
Mg may play a role in modulating cell growth. However, it
should be recalled that intracellular Mg is not significantly
modulated in endothelial cells chronically exposed to low
concentrations of the cation [38].
Since (i) Mg deficiency activates an inflammatory
response and elevates the concentration of circulating
cytokines in rodents and (ii) IL-1, a pro-inflammatory
cytokine, is a potent inhibitor of endothelial cell growth,
we anticipated that an up-regulation of IL-1 may be
responsible for the growth inhibition observed in HUVEC
cultured in low Mg. Indeed, IL-1 was up-regulated and an
antisense oligonucleotide against IL-1 could prevent the
growth inhibition observed in cells exposed to low con-
centrations of the cation. Apart from its effect on cell
growth, IL-1 profoundly affects endothelial gene expres-
sion [1]. Indeed, it is conceivable that the up-regulation of
VCAM and PAI-1 we detected after Mg deficiency might
be ascribed to the high levels of IL-1 synthesized. How-
ever, it is unlikely that all the effects we observe are due to
the up-regulation of IL-1. For instance, IL-1 induces the
expression of E-selectin and ICAM-1 and we did not
detect any modulation of these adhesion molecules in
our system (unpublished results). We propose that VCAM
is responsible, at least in part, of the increased adhesion of
monocytoid U937 cells to the endothelial monolayer. The
overexpression of VCAM and PAI-1 may contribute to the
high incidence of atherosclerotic lesions and thromboticevents observed in Mg deficiency both in experimental
models and in patients.
It is noteworthy that Mg deprivation has been linked to
an exaggerated response to immune stresses in experimental
models [10]. Analogously, we found that low Mg renders
endothelial cells more susceptible to the detrimental effect
of LPS. We propose that low Mg promotes an inflammatory
response of endothelium which could be exacerbated by
immune stress. This could be of particular importance in
patients chronically affected by low Mg status, such as
diabetics, alcoholics, intensive care unit and cancer patients.
By cDNA array, we isolated several transcripts modulat-
ed in HUVEC grown in media containing low Mg. We
observed the up-regulation of AXL, the receptor for
Growth-arrested-specific gene (Gas)-6, which has been
shown to protect HUVEC from apoptosis [39]. It is note-
worthy that AXL and Gas-6 expression are temporally
correlated with neointima formation [40]. The down-regu-
lation of several molecules has been detected: ezrin, CD9,
cytohesin and zyxin, all contributing to endothelial adhesion
to substrates and migration. By Western blot analysis, we
confirmed the down-regulation of c-src, which is required
for endothelial migration. This result can explain, at least in
part, the reduced response of HUVEC to chemotactic factors
in low Mg media. Accordingly, a recent report has proposed
Mg as a newly recognized receptor-mediated chemoattrac-
tant for endothelial cells [41]. Together with proliferation,
cell migration is pivotal in angiogenesis. These results may
have implications in different situations, from tumor growth
and metastatization to wound healing.
Previous works have linked low levels of Mg to dyslipi-
demia, which would be responsible for atherogenesis. Our
data show that low magnesium directly affects endothelial
cells, therefore indicating that the endothelial dysfunction
caused by low Mg can contribute to generate a pro-inflam-
matory, pro-thrombotic and pro-atherogenic environment
leading to cardiovascular disease.Acknowledgements
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